26/11/2015 – Inselspital: “ARTORG and Inselspital develop artificial pancreas“
Artificial pancreas devices so far cannot compensate the daily varying food intake or physical activities of diabetes patients. The University of Bern, the Bern University Hospital and an industry partner have therefore set out to develop a more flexible device to continuously control patients’ blood sugar.
Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital “Inselspital” are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas.